@prometheuslab

A leader of precision healthcare in gastroenterology, offering novel diagnostic testing services to help physicians provide the highest level of patient care

 San Diego, CA
prometheuslabs.com
Joined April 2021
  • Tweets327
  • Following125
  • Followers66
280Media
Prometheus Laboratories retweeted
Uma Mahadevan@UmaMahadevanIBD8 Sep 2024
Correction: Infant less than mom!
Uma Mahadevan@UmaMahadevanIBD8 Sep 2024
Risankizumab, IgG1, has lower than expected placental transfer rates with infant > mom. @MLongMD @PIANOIBD @UCSFHospitals Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease academic.oup.com/ibdjournal/…

Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease

To the Editor,

academic.oup.com
2
11
1,653
Prometheus Laboratories retweeted
Emily Wright@DrEmilyWright9 Sep 2023
pubmed.ncbi.nlm.nih.gov/3759… Proud of the collaboration @prometheuslab. Important work in assisting with drug selection and personalisation of care in IBD.
2
10
893
Prometheus Laboratories retweeted
Robert Battat MD@BattatMD4IBD30 Aug 2023
The relationship between endoscopic healing index, fcal and mre. Great work. By @EmilySSmithMD ! pubmed.ncbi.nlm.nih.gov/3764… @Dana_Lukin @DCharabaty @IBDimmunology

The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance...

Both EHI and FCAL were specific in their confirmation of inflammation and disease activity on MRE in patients with CD. However, MRE-detected inflammation was frequently present in the presence of low...

pubmed.ncbi.nlm.nih.gov
1
7
19
1,762
Prometheus Laboratories retweeted
JPGN@JPGNonline4 Dec 2022
Lawrence et al compared standard induction with #IFX vs optimized induction in #children with #IBD finding that optimized induction was associated with ⬆️ odds of achieving long-term clinical remission. bit.ly/3ESKfo0
8
1
6
Prometheus Laboratories retweeted
IBDJournal & CC360@IBDJournals28 Sep 2022
Proactive infliximab optimization during induction guided by a pharmacokinetics dashboard improves IFX durability and immunogenicity. <8% of pts were ADA ➕ by end of induction & most ADAs were transient. bit.ly/3RDarI3

Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and...

AbstractBackground and Aims. Accelerated infliximab (IFX) induction is often based on clinical parameters as opposed to pharmacokinetics (PK). We aimed to

academic.oup.com
4
23
#ACG2021 🔺Is the risk of anti-drug antibodies (ADA) inevitable in + HLA-DQA1*05 #PANTS? @pedsIBDdoc shows that 💎Achieving target drug level at 🔑induction🔑 can overcome HLA-risk of ADA 💎Proactive #TDM at induction can replace need for combo Rx w TNFi to prevent ADA
1
8
27
Prometheus Laboratories retweeted
John Damianos, M.D.@john_damianosMD24 Oct 2021
⬆️ level is associated with ⬆️ response
1
1
1
Prometheus Laboratories retweeted
Ryan Ungaro MD MS@ryanungaro18 Sep 2021
Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations | Inflammatory Bowel Diseases | Oxford Academic academic.oup.com/ibdjournal/…

Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of...

Infliximab (IFX), a chimeric monoclonal antibody targeting tumor necrosis factor-α, is an important anticytokine treatment for inflammatory bowel disease (

academic.oup.com
10
29
7
102
Prometheus Laboratories retweeted
Robert Battat MD@BattatMD4IBD27 Sep 2021
More data supporting #tdm in #ibd for tnf antagonists and ustekinumab onlinelibrary.wiley.com/doi/… @waqqasafif @IBD_FloMD @guthealthmd @DCharabaty
5
20
Prometheus Laboratories retweeted
Robert Battat MD@BattatMD4IBD12 Jun 2021
Serum Ustekinumab Concentrations are Associated with Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index | Crohn's & Colitis 360 | Oxford Academic ⁦@guthealthmd⁩ ⁦@waqqasafif⁩ academic.oup.com/crohnscolit…
13
27
Load more